RVL Pharmaceuticals (OSMT)
NASDAQ: OSMT
· Real-Time Price · USD
1.11
-0.02 (-1.77%)
At close: Jan 19, 2022, 6:00 AM
RVL Pharmaceuticals Revenue
RVL Pharmaceuticals reported an annual revenue of $177.88M, reflecting a 184.1% growth. For the quarter ending September 30, 2021, RVL Pharmaceuticals generated $2.2M in revenue.
Revenue (ttm)
49.72M
Revenue Growth
184.1%
Price / Sales Ratio
2.02
Revenue / Employee
164.64K
Employees
302
Market Cap
110.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2020 | 177.88M | -25.89% |
| Dec 31, 2019 | 240.03M | -8.98% |
| Dec 31, 2018 | 263.7M | +7.31% |
| Dec 31, 2017 | 245.75M | +12.49% |
| Dec 31, 2016 | 218.46M | n/a |